Ovid Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	28.97	46.8	189.73	72.03	41.9	36.49	87.13	51.94	69.94
Short-Term Investments	78.79	84.13	0	0	34.84	5.01	0	0	0
Cash & Cash Equivalents	107.76	130.93	189.73	72.03	76.74	41.5	87.13	51.94	69.94
Cash Growth	-17.69%	-30.99%	163.39%	-6.13%	84.91%	-52.37%	67.74%	-25.74%	-
Receivables	0	0	0	0.14	1.13	0.6	0	0.01	0.06
Other Current Assets	1.83	0.45	0.75	2.67	1.94	2.17	1.46	0.46	0.28
Total Current Assets	109.6	131.38	190.48	74.84	79.81	44.27	88.59	52.41	70.28
Property, Plant & Equipment	14.66	16.07	0.24	0.14	0.07	0.07	0.05	0.04	0.03
Long-Term Investments	17.63	5.62	1.63	0	0	0	0	0	0
Other Long-Term Assets	2.14	2.19	2.19	0.95	0.96	3.31	0.82	0.57	0.06
Total Long-Term Assets	34.43	23.89	4.07	1.08	1.03	3.38	0.87	0.62	0.09
Total Assets	144.03	155.27	194.54	75.93	80.84	47.65	89.46	53.03	70.38
Accounts Payable	3.7	1.95	7.13	7.88	3.55	3.76	2.03	0.86	0.67
Deferred Revenue	0	0	0	12.38	0	0	0	0	0
Current Debt	1.25	0.53	0	0	0	0	0	0	0
Other Current Liabilities	6.53	4.5	7.67	1.8	6.98	5.09	4	2.88	1.64
Total Current Liabilities	11.47	6.99	14.8	22.06	10.53	8.84	6.02	3.73	2.31
Long-Term Debt	44.76	16	0	0	0	0	0	0	0
Other Long-Term Liabilities	0	0	0	10.23	0.29	0	0	0	0
Total Long-Term Liabilities	44.76	16	0	10.23	0.29	0	0	0	0
Total Liabilities	56.23	22.99	14.8	32.29	10.82	8.84	6.02	3.73	2.31
Total Debt	46	16.54	0	0	0	0	0	0	0
Debt Growth	178.20%	-	-	-	-	-	-	-	-
Retained Earnings	-277.87	-225.53	-171.36	-294.19	-213.16	-152.7	-100.72	-35.91	-13.5
Comprehensive Income	0	-0.04	0	0	0	-0	0	0	0
Shareholders' Equity	87.8	132.27	179.75	43.63	70.02	38.81	83.44	49.29	68.07
Net Cash / Debt	61.76	114.4	189.73	72.03	76.74	41.5	87.13	51.94	69.94
Net Cash / Debt Growth	-46.01%	-39.71%	163.39%	-6.13%	84.91%	-52.37%	67.74%	-25.74%	-
Net Cash Per Share	0.88	1.62	2.79	1.23	1.96	1.68	4.50	5.28	7.21
Working Capital	98.12	124.39	175.68	52.78	69.28	35.42	82.57	48.68	67.97
Book Value Per Share	1.24	1.88	2.66	0.75	1.79	1.57	4.31	5.01	7.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).